ArticleBlood cancer journal2026

A myeloid-dormant metabolic transcriptome identifies a poor-prognosis subgroup in hyperdiploid multiple myeloma with targetable vulnerabilities.

Naroa Barrena et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.